Oral Session 2-11A AML: Clinical Study (1)

[OS2-11A-5] Clinical significance of Flt3-ITD allelic ratio and ITD length in cytogenetically normal AML

Daisuke Hidaka¹, Masahiro Onozawa¹, Shinichi Fujisawa², Satoshi Yamamoto³, Yutaka Tsutsumi⁴, Yoshihito Haseyama⁵, Takahiro Nagashima⁶, Akio Mori⁷, Shuichi Ota⁸, Hajime Sakai⁹, Toshimichi Ishihara¹⁰, Takuto Miyagishima¹¹, Yasutaka Kakinoki¹², Mitsutoshi Kurosawa¹³, Hajime Kobayashi¹⁴, Hiroshi Iwasaki¹⁵, Takeshi Kondo⁷, Takanori Teshima^1,2 (1.Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan, 2.Division of Laboratory and Transfusion, Hokkaido University Hospital, Sapporo, Japan, 3.Sapporo City General Hospital, Sapporo, Japan, 4.Hakodate Municipal Hospital, Hakodate, Japan, 5.Tonan Hospital, Sapporo, Japan, 6.Japanese Red Cross Kitami Hospital, Kitami, Japan, 7.Aiiku Hospital, Sapporo, Japan, 8.Sapporo Hokuyu Hospital, Sapporo, Japan, 9.Teine Keijinkai Hospital, Sapporo, Japan, 10.Kin-ikyo Chuo Hospital, Sapporo, Japan, 11.Kushiro Rosai Hospital, Kushiro, Japan, 12.Asahikawa City Hospital, Asahikawa, Japan, 13.Hokkaido Cancer Center, Sapporo, Japan, 14.Obihiro Kosei General Hospital, Obihiro, Japan, 15.Sapporo Kosei General Hospital, Sapporo, Japan)